Todd Ente

Todd Ente currently serves as a Uro-Oncology Account Manager at Sumitomo Pharma America, Inc., starting in July 2023, where achievements include being a Circle of Excellence Winner and Regional MVP Winner for FY 2023. Prior to this role, Todd was also a Uro-Oncology Account Manager at Myovant Sciences from November 2020 to July 2023, during which Todd launched Orgovyx (Relugolix) in key markets. Experience includes a significant tenure at EMD Serono, Inc. as an Immuno-Oncology Territory Business Manager, recognized with the President's Club and Elite Awards in FY 2019 and 2018 respectively, as well as contributions to the launch of Avelumab in Immuno-Oncology. Earlier, Todd was with GSK for nearly two decades in various senior roles, establishing strong relationships with major cancer centers and successfully launching multiple cancer therapies. Todd holds a Bachelor's degree in Communications from American University in Washington D.C.